An efficient three-step synthetic route to imidazolefused benzodiazepines from imidazole-2-carbaldehyde is described. Application of intramolecular Buchwald-Hartwig cycloamination reaction in the final step is shown to be a convenient method for the synthesis of fused seven-membered diazacycles. The reactions proceeded smoothly with both aliphatic and aromatic amines.
There is a growing interest over the past few years in the synthesis of nitrogen containing heterocycle-fused benzazepines and benzodiazepines due to their crucial role as main structural motif in many pharmacologically active molecules. The clinical importance and commercial success associated with the benzodiazepine class of central nervous system (CNS)-active agents and the utility of 1,4diazepines as peptidomimetic scaffolds have led the medicinal chemists to recognize them as privileged structures. Particularly, imidazobenzodiazepines 1 and related ligands interact selectively for a neuro-inhibitory, postsynaptic GABA A receptor 1f,g with high affinity. Accordingly, they may act as agonists, partial agonists, 1b and antagonists. The therapeutic applications of benzodiazepines include anxiolytics, 2 antiarrhythmics, 3 vasopressin antagonists, 4 and cholecystokinin antagonists. 5 Some of the benzodiazepines such as arfendazam, lofendazam, 6 triflubazam, 7 and clobazam exhibit a wide range of biological activities while others like telenzepine act as antisecretory agents. 8 Recently, several compounds have been formally licensed for clinical use (e.g., Nevirapine) and others are at the preclinical and/or clinical development stage (e.g., Tivirapine and UK-129 485 9 ). Tetrahydroimidazo [4,5,1-jk] [l,4] benzodiazepin-2(1H)-thione, assigned the acronym TIBO, 1d,e is the first member of a series of potent selective and noncompetitive inhibitors of HIV-l reverse transcriptase. Despite the immense importance of imidazobenzodiazepines, only a few groups 1 have reported their synthesis. These methods either require lengthy sequence of reactions or harsh reaction conditions. For quite some time, we have been engaged in the synthesis of several benzannulated and dibenzannulated medium ring heterocycles employing palladium-catalyzed intramolecular C-N bond forming cyclization reaction. [10] [11] [12] The copper-or palladium-catalyzed intramolecular Buchwald-Hartwig aryl amination reaction 13 appeared particularly suitable for this purpose. In continuation of these efforts, we became interested in applying this method in the synthesis of imidazole-fused benzodiazepines. To the best of our knowledge no other group has reported the synthesis of this important synthetic target using this method. The requisite starting materials 3a-c were prepared in good to excellent yields by reaction between imidazole-2carbaldehyde (1) and either 2-bromobenzyl bromide (2a) or substituted 2-bromobenzyl bromides 2b,c in the presence of anhydrous potassium carbonate in anhydrous DMF at room temperature (Table 1) .
Imine formation with aliphatic and aromatic amines and subsequent NaBH 4 reduction in ethanol afforded the desired amine precursors 4a-l in good yields ( Table 2 ).
The amine precursor 4a was then used as model substrate for the optimization of intramolecular cycloamination reaction. Initially with the conditions used by Buchwald 13a (Table 3 , entry 1) no desired product was obtained and the starting material 4a was recovered. Changing the catalyst to Pd 2 (dba) 3 or Pd(OAc) 2 also failed to afford the desired product in the absence of a ligand (entries 2, 3). The reaction did take place in the presence of a ligand, with Pd 2 (dba) 3 proving superior to Pd(OAc) 2 at equivalent (10 mol% Pd) catalyst loading (entries 4-7), but the yield was still low (58%). Then, the Pd loading was varied from 6 to 40 mol% using Pd 2 (dba) 3 as Pd source, which improved the yield to 73% at 20% Pd loading (entry 9). Changing the base to Cs 2 CO 3 , using other monodentate (tri-o-tolylphosphine) or bidentate (DPPF) ligands and employing different solvents (DME or 1,4-dioxane) proved less satisfactory (entries 12-16).
Use of copper catalyst (CuI, 5 mol%) and t-BuOK (2 equiv) with different ligands [1,10- phenanthroline or (±)trans-1,2-cyclohexanediamine or N,N′-dimethylethylenediamine, 10 mol%] and solvents like DMF (at 120°C) or toluene (reflux) also did not lead to the desired cyclic product.
The optimized protocol for the palladium-catalyzed intramolecular aryl amination of 4a thus employs Pd 2 (dba) 3 (10 mol%) as catalyst, (±)-BINAP (10 mol%) as ligand, t-BuOK (2 equiv) as base, and toluene as solvent at reflux to furnish 5a. Employing these conditions, other substrates 4b-l were treated to afford 5b-l in 63-76% yield ( Table 4) . A probable mechanism 13b,c,14 of intramolecular aryl amination for the synthesis of benzodiazepines is outlined in Scheme 1.
The assigned structures of 5b-l were determined on the basis of their IR, 1 H NMR, 13 C NMR, mass spectra, and elemental analysis. The 1 H NMR spectrum of 5a consisted of two singlets at δ = 4.95 and 4.86 for the benzylic methylene protons and methylene protons attached to ni- trogen of the aniline moiety, along with signals for eleven aromatic protons (δ = 6.77-7.42). The 13 C NMR spectrum showed signals assignable to 17 carbons in agreement with the structure. The mass spectrum displayed a peak at m/z 262 for the [M + H] + ion. The features of the 1 H and 13 C NMR spectra of compounds 5b-l were broadly similar to those of 5a, except for the signals for the aromatic moieties and the alkyl/aryl groups, which exhibited the expected changes in signal patterns.
The present strategy thus establishes transition-metalcatalyzed cycloamination as a suitable synthetic tool for the preparation of imidazole-fused benzodiazepine. But it could not be extended to the synthesis of pyrrole-fused benzodiazepines.
In summary, we have established a straightforward efficient three-step synthetic route to imidazole-fused sevenmembered diazacycles from imidazole-2-carbaldehyde using palladium-catalyzed intramolecular cycloamination reaction as the key step. Development of new analogues of benzodiazepines is highly desirable as this may lead to a promising antidepressant drug. This finding opens up the possibility of obtaining synthetically challenging imidazole-fused seven-membered benzoheterocycles.
Reactions at r.t. imply a temperature of 25 °C. Required reagents were obtained from commercial sources and used without purification. The solvents used were of technical grade, and freshly distilled prior to use. All melting points were obtained on a laboratory melting point bath and are uncorrected. 1 3.76; N, 9.49. Found: C, 48.64; H, 3.80; N, 9. 59.
1-(2-Bromobenzyl)-2-(phenylaminomethyl)-1H-imidazoles 4al; General Procedure
To an ethanolic solution (20 mL) of 3a-c (0.85-1.89 mmol, 1 equiv) was added the respective alkyl/aryl amine (1.27-2.83 mmol, 1.5 equiv) and the reaction mixture was stirred at r.t. for 12 h. After cooling to 0°C, NaBH 4 (2.12-4.72 mmol, 2.5 equiv) was added portionwise and the mixture was stirred for 2-3 h. On completion of the reaction as monitored by TLC (eluent: EtOAc), the solvent was removed under vacuum. The mixture was extracted with EtOAc (2 × 20 mL), and the combined organic extracts were washed with sat. aq NaHCO 3 (25 mL) and H 2 O (2 × 20 mL), dried (Na 2 SO 4 ), filtered, and concentrated. The crude residue was purified by column chromatography over neutral alumina (EtOAc-PE, 3:1) to afford the compounds 4a-l. This document was downloaded for personal use only. Unauthorized distribution is strictly prohibited. , 4.87; N, 11.29. Found: C, 58.28; H, 4.90; N, 11 .40.
1-(2-Bromo-5-methoxybenzyl)-2-(benzylaminomethyl)-1H-imidazole (4f)
Yield: 0.36 g (74%); yellowish sticky mass; R f = 0.4 (EtOAc). IR (neat): 2934 IR (neat): , 2838 IR (neat): , 1645 IR (neat): , 1594 IR (neat): , 1469 IR (neat): , 1350 IR (neat): , 1288 IR (neat): , 1239 IR (neat): , 1161 IR (neat): , 1020 , 5.22; N, 10.88. Found: C, 59.28; H, 5.19 ; N, 10.98.
1-(2-Bromo-5-methoxybenzyl)-2-(3,4-methylenedioxybenzylaminomethyl)-1H-imidazole (4g)
Yield: 0.32 g (71%); pale brownish sticky mass; R f = 0.26 (EtOAc). (neat): 2928, 1720, 1597, 1480, 1245, 1121, 1040, 930, 809, 739 cm -1 . , 4.68; N, 9.77. Found: C, 54.63; H, 4.64; N, 9. 90.
IR

1-(2-Bromo-4,5-methylenedioxybenzyl)-2-(isopropylaminomethyl)-1H-imidazole (4h)
Yield: 0.46 g (69%); pale yellowish sticky mass; R f = 0.28 (PE-EtOAc, 3:7). IR (neat): 3263, 2963, 2909, 1683, 1488, 1374, 1243, 1162, 1109, 1034, 929, 847, 733, 509 , 5.15; N, 11.93. Found: C, 51.35; H, 5.10; N, 11 .81. Bromo-4,5-methylenedioxybenzyl 1-(2-Bromo-4,5-methylenedioxybenzyl)-2-(phenylaminomethyl) , 4.18; N, 10.88. Found: C, 55.77; H, 4.13; N, 10. 98.
1-(2-
1-(2-Bromo-4,5-methylenedioxybenzyl)-2-(4-methoxyphenylaminomethyl)-1H-imidazole (4k)
Yield: 0.27 g (75%); brownish sticky mass; R f = 0.61 (PE-EtOAc, 3:7). IR (neat): 2919, 2842, 1622, 1510, 1480, 1240, 1115, 1037, 930, 825 , 754 cm -1 . Anal. Calcd for C 19 H 18 BrN 3 O 3 : C, 54.82; H, 4.36; N, 10.09. Found: C, 54.72; H, 4.40; N, 10.19 . Bromo-4,5-methylenedioxybenzyl)-2-(3,4- Anal. Calcd for C 20 H 18 BrN 3 O 4 : C, 54.07; H, 4.08; N, 9.46. Found: C, 54.29; H, 4.03; N, 9.56 .
1-(2-
4,10-Dihydro-5H-imidazo[2,1-c][1,4]benzodiazepines 5a-l; General Procedure
To a stirred solution of 4a-l (0.92-1.63 mmol, 1 equiv) in anhyd toluene (15 mL) were added t-BuOK (1.84-3.26 mmol, 2 equiv), (±)-BINAP (10 mol%), and Pd 2 (dba) 3 (10 mol%, Pd: 20 mol%) . The reaction mixture was refluxed for 14-18 h under N 2 atmosphere. After completion of the reaction (monitored by TLC, eluent: EtOAc), toluene was evaporated under vacuum, and the mixture was extracted with EtOAc (3 × 20 mL 1588, 1496, 1429, 1365, 1304, 1273, 1237, 1211, 1153, 1081, 1036, 882, 841, 748, 695, 566 1496, 1439, 1375, 1245, 1201, 1125, 1033, 925, 866, 813, 732, 640, 540 cm -1 . 
